"The TriHealth Cancer Institute wields the power of the full TriHealth system, which has been named among the country's Top 100 Most Integrated Health Networks 13 times. From outcomes, to prudent management of resources, to caring and compassionate service, to innovative research, TriHealth operates in an environment of continuous quality improvement across its more than 80 locations. As the landscape of health care continues to evolve both nationally and locally, TriHealth is prepared to respond to the demand for more coordinated, patient-centered models of care with strong physician collaboration and leadership."

During the past decade, TriHealth Cancer Institute-Anderson conducted 132 clinical trials. In the 10-year time frame, 132 clinical trials started and 49 clinical trials were completed, i.e. on average, 37.1% percent of trials that started reached the finish line to date. In the past 5 years, 53 clinical trials started and 46 clinical trials were completed. i.e. 86.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "TriHealth Cancer Institute-Anderson" #1 sponsor was "National Cancer Institute (NCI)" with 77 trials, followed by "SWOG Cancer Research Network" with 29 trials sponsored, "Alliance for Clinical Trials in Oncology" with 20 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 16 trials sponsored and "NRG Oncology" with 16 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "TriHealth Cancer Institute-Anderson" #1 collaborator was "National Cancer Institute (NCI)" with 80 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Agenus Inc." with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "TriHealth Cancer Institute-Anderson" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Recurrent Ovarian Carcinoma" (7 trials), "Stage IV Lung Cancer AJCC v8" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials) and "Invasive Breast Carcinoma" (6 trials). Many other conditions were trialed in "TriHealth Cancer Institute-Anderson" in a lesser frequency.

Most popular intervention types in "TriHealth Cancer Institute-Anderson" are "Drug" (124 trials), "Other" (97 trials), "Biological" (73 trials), "Procedure" (46 trials) and "Radiation" (10 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (47 trials), "Quality-of-Life Assessment" (37 trials), "Computed Tomography" (27 trials), "Biospecimen Collection" (26 trials) and "Nivolumab" (26 trials). Other intervention names were less common.

The vast majority of trials in "TriHealth Cancer Institute-Anderson" are 128 trials for "All" genders, 27 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "TriHealth Cancer Institute-Anderson". undefined are not yet recruiting, 54 are recruiting, 76 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in TriHealth Cancer Institute-Anderson, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in TriHealth Cancer Institute-Anderson, 3 "Phase 1" clinical trials were conducted, 80 "Phase 2" clinical trials and 75 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".